Skip to main navigation menu Skip to main content Skip to site footer

Original research

Vol. 4 No. 1 (2026): January/December - 2026

Clinical and Epidemiological Characteristics of Lymph Node Tuberculosis: A Retrospective Observational Study

DOI
https://doi.org/10.52600/2965-0968.bjcmr.2026.4.1.bjcmr58
Submitted
February 9, 2026
Published
2026-03-05

Abstract

Lymph node tuberculosis is the most common form of extrapulmonary tuberculosis and remains a diagnostic challenge due to nonspecific clinical manifestations and low microbiological confirmation rates. To describe the clinical, epidemiological, and diagnostic characteristics of patients with lymph node tuberculosis and to evaluate associations between clinical variables, lymph node localization, and short-term outcomes. A retrospective observational study was conducted including 66 patients diagnosed with lymph node tuberculosis. Demographic, clinical, histopathological, and microbiological variables were analyzed. Associations between categorical variables were assessed using Pearson’s chi-square or Fisher’s exact test, and age comparisons were performed using one-way ANOVA or Kruskal–Walli’s test. The mean age was 38.1 ± 11.6 years, and 54.5% of patients were male. Constitutional symptoms were present in 92.4% of cases, while cough was absent in most patients (92.4%). Cervical lymph nodes were the most frequently affected (48.5%). Caseating granuloma was identified in 7.6%, and mycobacterial culture was positive in 27.3%. Significant associations were observed between lymph node localization and sex, constitutional symptoms, and histopathological findings (all p < 0.001). Lymph node tuberculosis predominantly affects young adults and presents mainly with systemic symptoms and cervical lymphadenopathy. Despite limited diagnostic confirmation, short-term outcomes were favorable.

References

  1. World Health Organization. Global tuberculosis report 2023. Geneva: WHO; 2023.
  2. Fontanilla JM, Barnes A, von Reyn CF. Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis. 2011;53(6):555–562.
  3. Handa U, Mundi I, Mohan S. Nodal tuberculosis revisited: a review. J Infect Dev Ctries. 2012;6(1):6–12.
  4. Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician. 2005;72(9):1761–1768.
  5. Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis. 2015;78(2):47–55.
  6. Rock RB, et al. Pathogenesis of Mycobacterium tuberculosis. Clin Microbiol Rev. 2008;21(2):243–266.
  7. von Elm E, Altman DG, Egger M, et al. The STROBE statement. PLoS Med. 2007;4(10):e296.